Greenleaf Trust Purchases 432 Shares of Cardinal Health, Inc. (NYSE:CAH)

Greenleaf Trust lifted its position in Cardinal Health, Inc. (NYSE:CAH) by 9.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,125 shares of the company’s stock after acquiring an additional 432 shares during the quarter. Greenleaf Trust’s holdings in Cardinal Health were worth $517,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in CAH. Ameriprise Financial Inc. increased its position in Cardinal Health by 82.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 4,128,009 shares of the company’s stock valued at $358,390,000 after purchasing an additional 1,862,291 shares during the period. International Assets Investment Management LLC purchased a new position in Cardinal Health during the 4th quarter valued at about $464,800,000. Deutsche Bank AG increased its position in Cardinal Health by 64.9% during the 3rd quarter. Deutsche Bank AG now owns 1,027,670 shares of the company’s stock valued at $89,222,000 after purchasing an additional 404,609 shares during the period. Pacer Advisors Inc. increased its position in Cardinal Health by 17.5% during the 4th quarter. Pacer Advisors Inc. now owns 2,619,561 shares of the company’s stock valued at $264,052,000 after purchasing an additional 389,431 shares during the period. Finally, Federated Hermes Inc. increased its position in Cardinal Health by 269.8% during the 3rd quarter. Federated Hermes Inc. now owns 253,335 shares of the company’s stock valued at $21,995,000 after purchasing an additional 184,823 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Down 5.0 %

CAH stock opened at $102.83 on Tuesday. The firm has a 50 day moving average of $109.58 and a 200 day moving average of $104.50. The stock has a market capitalization of $25.01 billion, a PE ratio of 40.48, a price-to-earnings-growth ratio of 1.04 and a beta of 0.68. Cardinal Health, Inc. has a 52 week low of $77.56 and a 52 week high of $116.04.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, February 1st. The company reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.56 by $0.26. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The company had revenue of $57.45 billion during the quarter, compared to analysts’ expectations of $57.02 billion. During the same period last year, the business earned $1.32 EPS. Cardinal Health’s revenue for the quarter was up 11.6% on a year-over-year basis. On average, equities research analysts expect that Cardinal Health, Inc. will post 7.28 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a dividend of $0.5006 per share. This represents a $2.00 annualized dividend and a yield of 1.95%. The ex-dividend date was Thursday, March 28th. Cardinal Health’s payout ratio is 78.74%.

Wall Street Analyst Weigh In

A number of research analysts have commented on CAH shares. TheStreet downgraded shares of Cardinal Health from a “b-” rating to a “c+” rating in a research report on Wednesday, December 27th. SVB Leerink initiated coverage on shares of Cardinal Health in a research report on Monday, February 26th. They issued an “outperform” rating and a $125.00 price objective on the stock. Leerink Partnrs reaffirmed an “outperform” rating on shares of Cardinal Health in a research report on Monday, February 26th. Barclays initiated coverage on shares of Cardinal Health in a research report on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 price objective on the stock. Finally, Argus raised shares of Cardinal Health from a “hold” rating to a “buy” rating in a research report on Friday, February 9th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $103.07.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.